ArticleDiscover oncology2026

A real-world study of Trifluridine/Tipiracil (TAS-102) combined with bevacizumab as the late-line treatment of metastatic colorectal cancer.

Shaocheng Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.